Impaired Exercise Tolerance Early After Heart Transplantation Is Associated With Development of Cardiac Allograft Vasculopathy
| Autor: | Cara Joyce, Eugenia Raichlin, Scott Lundgren, Michael J. Moulton, Max Liebo, Brian D. Lowes, John Y. Um, Ronald Zolty, Mingxi D. Yu, Ahmed M. Salim |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Databases Factual Health Status medicine.medical_treatment Coronary Artery Disease 030230 surgery Coronary Angiography Cardiac allograft vasculopathy Metabolic equivalent Young Adult 03 medical and health sciences Oxygen Consumption 0302 clinical medicine Risk Factors Interquartile range Internal medicine Cardiopulmonary exercise test medicine Humans Aged Retrospective Studies Heart transplantation Transplantation Exercise Tolerance business.industry Middle Aged Exercise capacity Treatment Outcome Cardiorespiratory Fitness Exercise Test Cardiology Heart Transplantation Female 030211 gastroenterology & hepatology Impaired exercise tolerance Pulmonary Ventilation business Respiratory minute volume |
| Zdroj: | Transplantation. 104:2196-2203 |
| ISSN: | 0041-1337 |
| DOI: | 10.1097/tp.0000000000003110 |
| Popis: | Background Exercise performance remains limited in some patients after heart transplantation (HTx). The goal of this study was to assess for association between cardiopulmonary exercise test performance at 1 year after HTx and future development of cardiac allograft vasculopathy (CAV). Methods Overall 243 HTx recipients performed cardiopulmonary exercise testing at 1 year after HTx. During the median follow-up period of 31 (interquartile range 19;61) months, 76 (32%) patients were diagnosed with CAV (CAV group). Results The CAV group patients had lower exercise capacity (5.2 ± 1.9 versus 6.5 ± 2.2 metabolic equivalents; P = 0.001) and duration (9.6 ± 3.5 versus 11.4 ± 4.8 min; P = 0.008), lower peak oxygen consumption (VO2) (18.4 ± 5.4 versus 21.4 ± 6.1 mL/kg/min; P = 0.0005), lower normalized peak VO2 (63% ± 18% versus 71% ± 19%; P = 0.007), and higher minute ventilation (VE)/carbon dioxide production (VCO2) (34 ± 5 versus 32 ± 5, P = 0.04). On Cox proportional hazards regression analysis, normalized peak VO2 ≤60%, and VE/VCO2 ≥34 were associated with a high hazard for CAV (HR = 1.8 [95% CI 1.10-4.53, P = 0.03] and 2.5 [95% CI 1.01-8.81, P = 0.04], respectively). The subgroup of patients with both normalized peak VO2 ≤60% and VE/VCO2 ≥34 was at highest risk for development of CAV (HR = 5.2, 95% CI 2.27-15.17, P = 0.001). Conclusions Normalized peak VO2 ≤60% and VE/VCO2 ≥34 at 1 year after HTx are associated with the development of CAV. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|